In addition, we also identified EMT genes that had only been described in a sub-set of malignant disease states, but were previously unknown in prostate cancer (e.g. LSR, S11A14, DPYSL3), implying a common EMT program across multiple cancer types. This evidence concerns the gene DPYSL3 and cancer.